Clinical trial
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With…
NCT00003857 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003857 |
|---|---|
| Title | Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ |
| Official title | Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus Radiation Therapy for Good Risk Duct Carcinoma In-Situ (DCIS) of the Female Breast |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B NCIC Clinical Trials Group NRG Oncology |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | tamoxifen citrate, adjuvant therapy, radiation therapy |
| Enrollment | 636 |
| Start date | Dec 1, 1999 |
| Primary completion | Feb 1, 2004 |
| Completion | May 20, 2022 |
| First posted | Jan 27, 2003 |
| Last update posted | May 25, 2022 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: